
PREVUE-VALVE Study Estimates More Than 10 Million Older Americans Have Valvular Heart Disease

Structural Heart and Valve Center at NewYork-Presbyterian and Columbia Advances Cardiac Care Through Innovation and Multidisciplinary Expertise

AI Model EchoNext Receives FDA Clearance to Aid Early Detection of Structural Heart Disease

NewYork-Presbyterian Team Among the First in the Nation to Implant New FDA-Approved Bioprosthetic Mitral Valve


Weill Cornell Medicine Research Shows Decline in Mitral Valve Repair for Anterior Mitral Leaflet Regurgitation

Highlights From the 2025 AATS Mitral Conclave

A Legacy of Leadership in Advancing TAVR

